Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 22453175)

1.

Misfolded PrP and a novel mechanism of proteasome inhibition.

Andre R, Tabrizi SJ.

Prion. 2012 Jan-Mar;6(1):32-6. doi: 10.4161/pri.6.1.18272. Review.

2.

Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.

Lin Z, Zhao D, Yang L.

Acta Biochim Biophys Sin (Shanghai). 2013 Jun;45(6):477-84. doi: 10.1093/abbs/gmt020. Epub 2013 Feb 28. Review.

PMID:
23449072
3.

Prions and the proteasome.

Deriziotis P, Tabrizi SJ.

Biochim Biophys Acta. 2008 Dec;1782(12):713-22. doi: 10.1016/j.bbadis.2008.06.011. Epub 2008 Jul 1. Review.

4.

Selective processing and metabolism of disease-causing mutant prion proteins.

Ashok A, Hegde RS.

PLoS Pathog. 2009 Jun;5(6):e1000479. doi: 10.1371/journal.ppat.1000479. Epub 2009 Jun 19.

5.

Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry.

Deriziotis P, André R, Smith DM, Goold R, Kinghorn KJ, Kristiansen M, Nathan JA, Rosenzweig R, Krutauz D, Glickman MH, Collinge J, Goldberg AL, Tabrizi SJ.

EMBO J. 2011 Jul 8;30(15):3065-77. doi: 10.1038/emboj.2011.224.

6.

Disease-associated prion protein oligomers inhibit the 26S proteasome.

Kristiansen M, Deriziotis P, Dimcheff DE, Jackson GS, Ovaa H, Naumann H, Clarke AR, van Leeuwen FW, Menéndez-Benito V, Dantuma NP, Portis JL, Collinge J, Tabrizi SJ.

Mol Cell. 2007 Apr 27;26(2):175-88.

7.

Conformational conversion of prion protein in prion diseases.

Zhou Z, Xiao G.

Acta Biochim Biophys Sin (Shanghai). 2013 Jun;45(6):465-76. doi: 10.1093/abbs/gmt027. Epub 2013 Apr 11. Review.

PMID:
23580591
8.

The relationship between the 20S proteasomes and prion-mediated neurodegenerations: potential therapeutic opportunities.

Cecarini V, Bonfili L, Cuccioloni M, Mozzicafreddo M, Angeletti M, Eleuteri AM.

Apoptosis. 2010 Nov;15(11):1322-35. doi: 10.1007/s10495-010-0480-1. Review.

PMID:
20213200
9.

Cyclosporin-A-induced prion protein aggresomes are dynamic quality-control cellular compartments.

Ben-Gedalya T, Lyakhovetsky R, Yedidia Y, Bejerano-Sagie M, Kogan NM, Karpuj MV, Kaganovich D, Cohen E.

J Cell Sci. 2011 Jun 1;124(Pt 11):1891-902. doi: 10.1242/jcs.077693. Epub 2011 May 10.

10.

Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.

Mishra RS, Bose S, Gu Y, Li R, Singh N.

J Alzheimers Dis. 2003 Feb;5(1):15-23.

PMID:
12590162
11.

Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.

Ma J, Wollmann R, Lindquist S.

Science. 2002 Nov 29;298(5599):1781-5. Epub 2002 Oct 17.

12.

Molecular mechanisms of neurotoxicity of pathological prion protein.

Castilla J, Hetz C, Soto C.

Curr Mol Med. 2004 Jun;4(4):397-403. Review.

PMID:
15354870
13.

Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.

Elmallah MI, Borgmeyer U, Betzel C, Redecke L.

Prion. 2013 Sep-Oct;7(5):404-11. doi: 10.4161/pri.26745. Epub 2013 Oct 9.

14.

Prion protein self-interactions: a gateway to novel therapeutic strategies?

Rigter A, Langeveld JP, van Zijderveld FG, Bossers A.

Vaccine. 2010 Nov 16;28(49):7810-23. doi: 10.1016/j.vaccine.2010.09.012. Epub 2010 Oct 20. Review.

PMID:
20932496
15.

Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis.

Kristiansen M, Messenger MJ, Klöhn PC, Brandner S, Wadsworth JD, Collinge J, Tabrizi SJ.

J Biol Chem. 2005 Nov 18;280(46):38851-61. Epub 2005 Sep 12.

16.

Prion protein oligomer and its neurotoxicity.

Huang P, Lian F, Wen Y, Guo C, Lin D.

Acta Biochim Biophys Sin (Shanghai). 2013 Jun;45(6):442-51. doi: 10.1093/abbs/gmt037. Epub 2013 Apr 4. Review.

PMID:
23557632
17.

Proteasome inhibitors promote the sequestration of PrPSc into aggresomes within the cytosol of prion-infected CAD neuronal cells.

Dron M, Dandoy-Dron F, Farooq Salamat MK, Laude H.

J Gen Virol. 2009 Aug;90(Pt 8):2050-60. doi: 10.1099/vir.0.010082-0. Epub 2009 Apr 1.

18.

Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.

Nunziante M, Ackermann K, Dietrich K, Wolf H, Gädtke L, Gilch S, Vorberg I, Groschup M, Schätzl HM.

J Biol Chem. 2011 Sep 30;286(39):33942-53. doi: 10.1074/jbc.M111.272617. Epub 2011 Aug 11.

19.

A hypothesis on prion disorders: are infectious, inherited, and sporadic causes so distinct?

Fornai F, Ferrucci M, Gesi M, Bandettini di Poggio A, Giorgi FS, Biagioni F, Paparelli A.

Brain Res Bull. 2006 Mar 31;69(2):95-100. Epub 2006 Jan 4. Review.

PMID:
16533656
20.

Cellular aspects of prion replication in vitro.

Grassmann A, Wolf H, Hofmann J, Graham J, Vorberg I.

Viruses. 2013 Jan 22;5(1):374-405. doi: 10.3390/v5010374. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk